When AAT levels were <2.189 g/dL, the sensitivity for predicting T2DM development in patients with obesity was low, whereas the specificity was high (90.0%), indicating a low false-positive rate. This evidence concerns the gene SERPINA1 and obesity due to melanocortin 4 receptor deficiency.